|本期目录/Table of Contents|

[1]戴道鹏,沈迎,张瑞岩,等.血清可溶性髓样细胞触发受体-1水平对冠状动脉粥样斑块进展的预测价值[J].国际心血管病杂志,2016,05:303-306.
　DAI Daopeng,SHEN Ying,ZHANG Ruiyan,et al.Value of serum soluble triggering receptor expressed on myeloid cells-1 level for predicting coronary plaque progression[J].International Journal of Cardiovascular Disease,2016,05:303-306.
点击复制

血清可溶性髓样细胞触发受体-1水平对冠状动脉粥样斑块进展的预测价值(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年05期
页码:
303-306
栏目:
临床研究
出版日期:
2016-09-20

文章信息/Info

Title:
Value of serum soluble triggering receptor expressed on myeloid cells-1 level for predicting coronary plaque progression
作者:
戴道鹏; 沈迎; 张瑞岩; 丁风华; 陆林; 陶蓉
200025 上海交通大学医学院附属瑞金医院心脏科
Author(s):
DAI Daopeng;  SHEN Ying;  ZHANG Ruiyan;  DING Fenghua;  LU Lin;  TAO Rong.
Department of Cardiology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
关键词:
可溶性髓样细胞触发受体-1; 冠状动脉粥样硬化性心脏病; 斑块进展
Keywords:
Soluble triggering receptor expressed on myeloid cells-1;  Coronary artery disease;  Plaque progression
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.05.013
文献标识码:
-
摘要:
目的:探讨冠状动脉(冠脉)粥样硬化性心脏病患者血清可溶性髓样细胞触发受体-1(sTREM-1)水平对冠脉粥样硬化斑块进展的预测价值。方法:入选82例稳定型心绞痛患者,检测首次冠脉造影前空腹血清sTREM-1水平,患者接受冠脉造影随访复查,根据冠脉病变定量分析结果将患者分为斑块进展组(n=47)和无斑块进展组(n=35)。结果:斑块进展组血清sTREM-1水平显著高于无斑块进展组[(349.57±222.89)pg/mL对(176.85±118.62)pg/m
Abstract:
Objective:To investigate the possible role of serum soluble triggering receptor expressed on myeloid cells-1(sTREM-1)level in predicting coronary plaque progression(PP)in patients with coronary atherosclerotic heart disease.Methods:82 patients with stable

参考文献/References

[1] Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease[J]. Circulation, 2006, 113(2): 203-212.
[2] Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[J]. New Engl J Med, 2002, 346(23): 1773-1780.
[3] Zairis MN, Ambrose JA, Manousakis SJ, et al. The impact of plasma levels of C-reactive protein, lipoprotein(a)and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study[J]. J Am Coll Cardiol, 2002, 40(8): 1375-1382.
[4] Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352(16):1685-1695.
[5] Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes[J]. J Immunol, 2000, 164(10): 4991-4995.
[6] Gingras MC, Lapillonne H, Margolin JF. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development[J]. Mol Immunol, 2002, 38(11): 817-824.
[7] Velásquez S, Matute JD, Gámez LY, et al. Characterization of nCD64 expression in neutrophils and levels of s-TREM-1 and HMGB-1 in patients with suspected infection admitted in an emergency department[J]. Biomedica, 2013, 33(4): 643-652.
[8] Gibot S, Kolopp-Sarda MN, Béné MC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis[J]. Ann Interrn Med, 2004, 141(1): 9-15.
[9] Boufenzer A, Lemarié J, Simon T, et al. TREM-1 mediates inflammatory injury and cardiac remodeling following myocardial infarction[J]. Circ Res, 2015, 116(11): 1772-1782.
[10] Fraker TD, Fihn SD. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina[J]. J Am Coll Cardiol, 2007, 50(23): 2264-2274.
[11] Zouridakis E, Avanzas P, Arroyo-Espliguero R, et al. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris[J]. Circulation, 2004, 110(13): 1747-1753.
[12] Zheng JL, Lu L, Hu J, et al. Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease[J]. Atherosclerosis, 2010, 210(2): 590-595.
[13] Mack WJ, Azen SP, Dunn M, et al. A comparison of quantitative computerized and human panel coronary endpoint measures: implications for the design of angiographic trials[J]. Control Clin Trials, 1997, 18(2): 168-179.
[14] 何流漾, 赵建中, 戚春建. 免疫细胞在动脉粥样硬化中的作用[J]. 国际心血管病杂志, 2013, 40(3): 139-141.
[15] 房 炎, 于 波. 支架内新生动脉粥样硬化斑块的研究进展[J]. 国际心血管病杂志, 2013, 40(1): 28-30.
[16] Prüfer S, Weber M, Sasca D, et al. Distinct signaling cascades of TREM-1, TLR and NLR in neutrophils and monocytic cells[J]. J Innate Immun, 2014, 6(3): 339-352.
[17] Netea MG, Azam T, Ferwerda G, et al. Triggering receptor expressed on myeloid cells-1(TREM-1)amplifies the signals induced by the NACHT-LRR(NLR)pattern recognition receptors[J]. J Leukocyte Biol, 2006, 80(6): 1454-1461.
[18] Gómez-Piña V, Soares-Schanoski A, Rodríguez-Rojas A, et al. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes[J]. J Immunol, 2007, 179(6): 4065-4073.

备注/Memo

备注/Memo:
通信作者:陶 蓉,Email:rongtao@hotmail.com
更新日期/Last Update: 2016-09-20